Inhibition of drug metabolism by blocking the activation of nuclear receptors by ketoconazoleHaiyan Huang, Sridhar Mani, H Wang et al.|Oncogene|2006Cited by 211
Inhibition of influenza virus replication via small molecules that induce the formation of higher-order nucleoprotein oligomersSamuel W. Gerritz, Mark Krystal, Shuhao Shi et al.|Proceedings of the National Academy of Sciences|2011Cited by 139
Fluorine Substitution Can Block CYP3A4 Metabolism-Dependent Inhibition: Identification of (<i>S</i>)<i>-N</i>-[1-(4-Fluoro-3- morpholin-4-ylphenyl)ethyl]-3- (4-fluorophenyl)acrylamide as an Orally Bioavailable KCNQ2 Opener Devoid of CYP3A4 Metabolism-Dependent InhibitionYong‐Jin Wu, Michael Sinz, Carl D. Davis et al.|Journal of Medicinal Chemistry|2003Cited by 59
Evaluation of Cynomolgus Monkey Pregnane X Receptor, Primary Hepatocyte, and in Vivo Pharmacokinetic Changes in Predicting Human CYP3A4 InductionSean Kim, Michael Sinz, Joseph Dinchuk et al.|Drug Metabolism and Disposition|2009Cited by 45
Identification of a broad-Spectrum azasordarin with improved pharmacokinetic propertiesMichael H. Serrano‐Wu, Balu Balasubramanian, Denis R. St. Laurent et al.|Bioorganic & Medicinal Chemistry Letters|2003Cited by 12